ABCELLERA BIOLOGICS INC (ABCL)

CA00288U1066 - Common Stock

2.89  +0.16 (+5.86%)

After market: 2.6417 -0.25 (-8.59%)

News Image
6 hours ago - The Motley Fool

AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript

ABCL earnings call for the period ending September 30, 2024.

News Image
12 hours ago - Chartmill

Which stocks are moving after the closing bell on Monday?

Stay updated with the stocks that are on the move in today's after-hours session.

News Image
13 hours ago - AbCellera Biologics Inc.

AbCellera Reports Q3 2024 Business Results

News Image
3 months ago - The Motley Fool

AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript

ABCL earnings call for the period ending June 30, 2024.

News Image
3 months ago - AbCellera Biologics Inc.

AbCellera Reports Q2 2024 Business Results

News Image
4 months ago - The Motley Fool

Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?

The Baker brothers are billionaires with a successful track record in the biopharmaceutical industry.

News Image
5 months ago - The Motley Fool

Down 57%, Is AbCellera Biologics a Buy on the Dip?

Wall Street analysts say this drug developer can more than double your money.

News Image
6 months ago - InvestorPlace

3 Stock Gems Hiding in the Nasdaq

If you don’t mind taking a risk in the discount section, these undervalued Nasdaq stocks just might surprise some folks.

News Image
6 months ago - The Motley Fool

AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript

ABCL earnings call for the period ending March 31, 2024.

News Image
6 months ago - InvestorPlace

ABCL Stock Earnings: AbCellera Biologics Beats EPS, Misses Revenue for Q1 2024

ABCL stock results show that AbCellera Biologics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

News Image
6 months ago - AbCellera Biologics Inc.

AbCellera Reports Q1 2024 Business Results